Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inge Dierynck

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Plos One|April 19, 2012
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trialsTara L Kieffer, Sandra De Meyer, Doug J Bartels, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2012
Design and synthesis of HIV-1 protease inhibitors for a long-acting injectable drug applicationBart Kesteleyn, Katie Amssoms, Wim Schepens, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Plos One|April 19, 2012
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trialsTara L Kieffer, Sandra De Meyer, Doug J Bartels, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2012
Design and synthesis of HIV-1 protease inhibitors for a long-acting injectable drug applicationBart Kesteleyn, Katie Amssoms, Wim Schepens, et al.
Pageof 3